.jpg)
products
.png)
Daptomycin
DAPTOMYCIN 500MG VIAL & 350MG VIALDaptomycin for injection is indicated for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, and Enterococcus faecalis (vancomycin-susceptible isolates only).
Enoxaparin Sodium Inj.
ENOXAPARIN SODIUM INJ., USP 30 mg/0.3 mL ENOXAPARIN SODIUM INJ., USP 40 mg/0.4 mL ENOXAPARIN SODIUM INJ., USP 60 mg/0.6 mL ENOXAPARIN SODIUM INJ., USP 80 mg/0.8 mL ENOXAPARIN SODIUM INJ., USP 100 mg/1 mL ENOXAPARIN SODIUM INJ., USP 120 mg/0.8 mL ENOXAPARIN SODIUM INJ., USP 150 mg/1 mL.png)
Fosaprepitant
FOSAPREPITANT 150MG VIALFosaprepitant for injection, in combination with other antiemetic agents, is indicated in adults for the prevention of: Acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin.
Delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).
.png)
Glycopyrrolate
GLYCOPYRROLATE Injection, USP 0.2 mg per 1 mLGLYCOPYRROLATE Injection, USP 0.4 mg per 2 mL
GLYCOPYRROLATE Injection, USP 1 mg per 5 mL
Glycopyrrolate is used in combination with other medications to treat ulcers in adults and children 12 years of age and older. Glycopyrrolate (Cuvposa) is used to reduce saliva and drooling in children between 3 and16 years of age that have certain medical conditions that cause drooling. Glycopyrrolate is in a class of medications called anticholinergics. It decreases stomach acid and saliva production by blocking the activity of a certain natural substance in the body.
.jpg)
Heparin Sodium Injection
HEPARIN SODIUM 5,000 USP units per .5 mLHEPARIN SODIUM 2,000 USP units per 2 mL Heparin inhibits reactions that lead to the clotting of blood and the formation of fibrin clots both in vitro and in vivo. Heparin acts at multiple sites in the normal coagulation system. Small amounts of heparin in combination with antithrombin III (heparin cofactor) can inhibit thrombosis by inactivating activated Factor X and inhibiting the conversion of prothrombin to thrombin. Once active thrombosis has developed, larger amounts of heparin can inhibit further coagulation by inactivating thrombin and preventing the conversion of fibrinogen to fibrin. Heparin also prevents the formation of a stable fibrin clot by inhibiting the activation of the fibrin stabilizing factor.
.jpg)
Neostigmine
NEOSTIGMINE METHYLSULFATE INJ 10MGNEOSTIGMINE INJ 5MG Neostigmine Methylsulfate Injection, a cholinesterase inhibitor, is indicated for reversal of the effects of nondepolarizing neuromuscular blocking agents (NMBA) after surgery.
.jpg)